Search

Your search keyword '"Bláha, M."' showing total 458 results
Start Over Author "Bláha, M."
458 results on '"Bláha, M."'

55. Abstract

Author

Bláha, M., Vaňásek, J., Široký, O., Malý, J., Hrnčíá, Z., Purkyně, J. E., Měrka, V., Špliňo, M., Měrka, V., Isakov, Y., Nemsadze, V., Podoprigora, G. I., Ginodman, H. A., Belokrysenko, S. S., Belokrysenko, S. S., Maltsev, V., Baranov, A., Gorbunova, E., Blüthner, K., Trávníček, J., Künzel, W., Štěpánková, R., Bartáková, J., Dronov, A., Mandel, L., Kasal, P., Král, J., Mydlil, V., Zoban, P., Král, J., Pospíšil, M., Hrodek, O., Ivašková, E., Morávek, F., Štěpánková, R., Svoboda, V., Ulmann, L., Goiš, M., Salajka, E., Menšík, J., Holub, A., Cabaj, W., and PrzyjaŁkowski, Z.

Published
1979
Full Text
View/download PDF

58. [Omentoplasty of the sternum--surgical solution in a sternal defect due to sternal osteomyelitis in a female patient with mediastinal localization of a parathyroid adenoma. Case report]

Author

Adámek S, Bláha M, Petr Libansky, Tvrdon J, and Nanka O

Subjects
Adenoma, Parathyroid Glands, Sternum, Parathyroid Neoplasms, Mediastinal Diseases, Humans, Female, Osteomyelitis, Choristoma, Middle Aged, Omentum
Abstract

We report here the case report of patient with empyema of the thorax and sternal osteomyelitis, which undertool removal of ectopic mediastinal parathyroid adenoma with omentoplasty of sternal defect. Osteomyelitis was cured; though empyema persisted for several months and it's healing was complicated with central venous catheter sepsis.

Published
2004

70. Changes of rheological and clinical parameters during the therapy of microcirculatory disorders

Author

Bláha, M., primary, Rencová, E., additional, Bláha, V., additional, Malý, R., additional, Blažek, M., additional, Studnička, J., additional, Andrýs, C., additional, Fátorová, I., additional, Filip, S., additional, Kašparová, M., additional, Procházková, R., additional, Malý, J., additional, Zimová, R., additional, and Langrová, H., additional

Published
2010
Full Text
View/download PDF

75. The importance of rheological parameters in the therapy of microcirculatory disorders

Author

Bláha, M., primary, Rencová, E., additional, Bláha, V., additional, Malý, R., additional, Blažek, M., additional, Studnička, J., additional, Andrýs, C., additional, Fátorová, I., additional, Filip, S., additional, Kašparová, M., additional, Procházková, R., additional, Malý, J., additional, Zimová, R., additional, and Langrová, H., additional

Published
2009
Full Text
View/download PDF

90. Extrakorporální eliminace cholesterolu u familiární hypercholesterolemie -- srovnání dvou metodik.

Author

Lánská, M., Bláha, M., and Žák, P.

Abstract

Introduction. Familial hypercholesterolemia is a hereditary disorder with autosomal dominant heredity. The underlying cause involves the gene for the LDL-receptor leading to accelerated atherosclerosis. Extracorporeal elimination of cholesterol (CH) is indicated in 3-5% of patients not responding to conservative treatment or in homozygous FH. Two methods are used at our institution: immunoadsorption of LDL- cholesterol and rheohemapheresis. Patients and Methods. We currently have long term follow-up available for 14 patients with familial hypercholesterolemia (8 males, 6 females) aged 28-70 years (median 57 years). 10 patients are treated with immunoadsorption (5 homozygous and 5 heterozygous) and 4 patients are treated with rheohemapheresis (2 males, 2 females). Median follow-up is 8.5 years. During immunoadsorption, plasma is collected by continuous separation and flows through alternating pairs of adsorbers in an automatic adsorbing-desorbing device. In rheohemapheresis, plasma is collected similarly but goes through a "second step" - filter. Procedures are repeated every 2-4 weeks. Cholesterol and LDL- cholesterol values are measured before and after each procedure. Results. 1922 procedures have been performed (immunoadsorption 1590 times, rheohemapheresis 332 times). Average cholesterol and LDL- cholesterol values before the procedure were 5.34 and 3.12 mmol/l in immunoadsorption, 5.07 and 2.86 in rheohemapharesis; after the procedure: 1.73 and 0.72 (a fall of 72% and 85%), resp. 1.96 and 0.97 mmol/l (a drop of 61% and 66% drop). Fibrinogen fell by 22% (from 3.05 to 2.42 g/l) and 64% (from 3.48 to 1.2g/l). There were 3.1% of adverse reactions and no difference was observed between the two methods. Conclusion. Treatment of FH is very effective when indicated. There is a significant decrease in all observed parameters. No patient experienced worsening of atherosclerosis. Both methods are safe with minimum adverse reactions. Immunoadsorption is more effective in CH elimination. RHF can be used in patients with hyperfibrinogenemia as an additional risk factor of atherosclerosis. Care of these patients is costly and requires an experienced team and an interdisciplinary approach. [ABSTRACT FROM AUTHOR]

Published
2014

91. Léčba percepční ztráty sluchu reohemaferézou - první zkušenosti.

Author

Dršata, J., Bláha, M., Chrobok, V., Rencová, E., and Lánská, M.

Subjects
*SENSORINEURAL hearing loss, *DEAFNESS, *INFUSION therapy, *TINNITUS treatment, *HEARING -- Physiological aspects
Abstract

Sudden hearing loss (sudden idiopathic sensorineural hearing loss, SISHL) is a major medical, social and economic problem. The etiology is not fully understood; the problem is arising presumably by the action of heterogeneous factors (viral infections, immunologic or vascular disorders etc.). Treatment of SISHL is generally not satisfactory, both in terms of corticosteroids or other options. Rheohemapheresis (RHF) offers a possibility of a rescue treatment. It is based on a rapid improvement of rheologic properties of blood that can favorably affect the viscosity and thus the flow of the microcirculation, coagulation or activity of the endothelium. In the years 2012-2013, we treated 16 patients in the age 34-72 years by means of our own modification of RHF, after treatment failure with corticoid infusion therapy. Hearing improvement was achieved significantly in 11 patients according to WHO rating, respectively in 12 diseased according to Fowler counting. 5 patients did not improve significantly, at one patient the hearing worsened. Most patients achieved an improvement at a frequency of 0.5 kHz. Tinnitus disappeared in two patients, and average tinnitus reduction was achieved 15.25 dB. Unfavorable prognostic factor showed to be the severity of hearing loss and age of the patient and the time of the incident. RHF side effects were not significant (two short-term non-serious reactions). RHF in our study showed a beneficial therapeutic effect even after a failed conventional therapy and subsequent initiation of treatment and was not associated with significant adverse risks. Treatment results of our group support the hypothesis that RHF may be an alternative rescue therapy in SISHL, especially in case of a vascular etiology, even after a failure of a standard therapy. [ABSTRACT FROM AUTHOR]

Published
2014

97. Panorama of adverse events during cytapheresis

Author

Stegmayr, B., Ptak, J., Nilsson, T., Berlin, G., Mirea, V., Axelsson, C.G., Griskevicius, A., Centoni, P., Liumbruno, G., Audzijoniene, J., Mokvist, K., Lassen, E., Knutson, F., Norda, R., Mörtzell, M., Prophet, H., Ramlow, W., Blaha, M., Witt, V., Efvergren, M., Tomaz, J., Newman, E., Eloot, S., Dhondt, A., Lalic, K., Sikole, A., Derfler, K., Hrdlickova, R., Tomsova, H., Gasova, Z., Bhuiyan-Ludvikova, Z., Ramsauer, B., and Vrielink, H.

Published
2013
Full Text
View/download PDF

98. Využití extrakorporální eliminace IgE v léčbě astmatu - zkušenosti jednoho centra.

Author

Lánská, M., Krčmová, I., Bláha, M., Novosad, J., and Žák, P.

Abstract

Copyright of Transfusiology & Haematology Today / Transfuze a Hematologie Dnes is the property of Czech Medical Association of JE Purkyne and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results